The Use of Persuasion in Print DTC Advertisements of Prescription Drugs: A Content Analysis of Leading Consumer Magazines from 1995–2000

Journal of Pharmaceutical Marketing and Management

Volumn 15, Issue 3, 2003, Pages 23-43

  Shah, Manish S ^a   Holmes, Erin R ^a   Desselle, Shane P ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

consumer magazines; content analysis; Direct to consumer advertising; persuasion; prescription drugs; unreferenced claims

Indexed keywords

EID: 84993704828     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v15n03_04     Document Type: Article

References (45)

1. Bradley LR, Zito TM. Direct-to-consumer prescription drug advertising. Med Care Capsule. 1997; 35 (1): 86 – 92.
2. Feisullin S, Sause SB. Update on direct-to-consumer advertising of prescription drugs. Am Pharm. 1991; N 531 (7): 47 – 52.
3. Parker BJ, Delene LM. Direct-to-consumer prescription drug advertising: Con-tent analysis and public policy implications. J Pharm Market Manage. 1998; 12 (4): 27 – 42.
4. Findlay S. Prescription drugs and mass media advertising. National Institute for Health Care Management Research Brief; September 2000.
5. Gebhart F. Rx sales for 1999. Drug Topics. 2000; 7: 31.
6. Pinto MB. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psych Rep. 2000; 86: 597 – 607.
7. Hunt M. Direct-to-consumer advertising of prescription drugs. National Health Policy Forum; April 1998.
8. Desselle SP, Aparasu R. Attitudinal dimensions that determine pharmacists' decisions to support DTCA of prescription medications. Drug Info J. 2000; 34: 103 – 14.
9. Pinto MB, Pinto JK, Barber JC. The impact of pharmaceutical direct advertis-ing: Opportunities and obstructions. Health Marketing Q. 1998; 15 (4): 89 – 101.
10. Terzian TV. Direct-to-consumer prescription drug advertising. Am J Law Med. 1999; 25 (1): 149 – 67.
11. Lipsky MS, Taylor CA. The opinions and experiences of family physicians re-garding direct-to-consumer advertising. J Fam Pract. 1997; 45: 495 – 9.
12. Kopp SW. Direct-to-consumer advertising and consumer prescription prices. Drug Inf J. 1996; 30: 59 – 65.
13. Juergens JP. Advertising in the American Journal of Hospital Pharmacy. Am J Hosp Pharm. 1987; 44: 1647 – 51.
14. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: Experts' assessments. Ann Intern Med. 1992; 116: 912 – 9.
15. Smith MC, Visconti JA. Appeals used in prescription drug advertising. Hosp Pharm. 1968; 3: 5 – 13.
16. Mburu FM, Smith MC, Wetherbee H. Humor in prescription drug advertising. Med Market Media. 1976; 11 (6): 38 – 45.
17. Smith MC, Strecker P, Hair J. Sex appeals in prescription drug advertising. Med Market Media. 1977; 12 (9): 65 – 72.
18. Smith MC, Griffin L. Rationality of appeals used in the promotion of psycho-tropic drugs. A comparison of male and female models. Soc Sci Med. 1977; 11: 409 – 14.
19. Seidenberg R. Images of health, illness and women in drug advertising. J Drug Iss. 1974; 4: 264 – 7.
20. Stimson G. Women in a doctored world. New Society. 1975; (May 1): 265 – 7.
21. Mant A, Darroch DB. Media images and medical images. Soc Sci Med. 1975; 9: 613 – 8.
22. Prather J, Fidell LS. Sex differences in the content and style of medical adver-tisements. Soc Sci Med. 1975; 9: 23 – 6.
23. McRee C, Corder BF, Haizlip T. Psychiatrists' responses to sexual bias in phar-maceutical advertising. Am J Psychiatry. 1974; 131: 1273 – 5.
24. Krupka LR, Verner AM. Prescription drug advertising: Trends and implica-tions. Soc Sci Med. 1985; 20: 191 – 7.
25. Krupka LR, Verner AM. Gender differences in drug (prescription, non-pre-scription, alcohol and tobacco) advertising: Trends and implications. J Drug Iss. 1992; 22: 339 – 60.
26. Smith MC. Portrayal of the elderly in prescription drug advertising. Gerontol. 1976; 16: 329 – 34.
27. Smith MC. Where are the blacks in prescription drug advertising? Med Market Media. 1977; 12: 47 – 9.
28. Hoog S. Over-the-counter drug advertising: Argumentation or persuasion. J Pharm Market Manage. 1994; 9 (2): 69 – 91.
29. Morris LA, Mazis MB, Brinberg D. Risk disclosures in televised prescription drug advertisements to consumers. J Public Policy Market. 1989; 8: 64 – 80.
30. Feather KR. Direct-to-consumer ads; still a big concern. Med Market Media. 1990; 25 (2): 40 – 4.
31. Schwartz H. Shifting sands of time. Pharm Exec. 1995; 15 (2): 20 – 2.
32. Everette SE. Lay audience response to prescription drug advertising. J Advertis Res. 1991; 31 (2): 43 – 9.
33. Keng A, Coley RM. Evaluating the accuracy of citations in drug promotional brochures. Ann Pharmacother. 1994; 28: 1231 – 5.
34. Christensen TP, Ascione FJ, Bagozzi RP. Understanding how elderly patients process drug information: A test of information processing. Pharm Res. 1997; 14: 1589 – 96.
35. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer adver-tisements for prescription drugs: What are Americans being sold? Lancet. 2000; 358(Oct 6): 1141 – 6.
36. Peyrot M, Alperstein NM, Van Doren D, Poli LG. Direct-to-consumer ads can influence behavior. Market Health Serv. 1998; 18 (2): 26 – 32.
37. Aday, LA. Deciding how many will be in sample. Designing and conducting health surveys. Chapter 7; 2nd Edition: 143.
38. Norenberg T. Direct to you-TV drug ads that make sense. FDA Consumer. 1998; 32(Jan-Feb): 7 – 10.
39. SPSS Base 10.0 User's Guide. Chicago: SPSS, Inc.; 1999.
40. Rust RT, Cooil B. Reliability measures for qualitative data: Theory and impli-cations. J Market Res. 1994; 31: 1 – 14.
41. Kassarjian FM. Content analysis in consumer behavior. J Consumer Res. 1997; 4 (2): 8 – 18.
42. West D. Mixing it up in the media. DTC Times. 1999; 6 – 18.
43. Smith Barney Research. The new women's movement: Women's healthcare. April 1997.
44. Levy S. Study finds strong consumer awareness of DTC Rx ads. Drug Topics. 2000; 13: 47.
45. Wechsler J. A conversation with FDA Commissioner Jane Henney on market-ing and risk management. Pharm Exec. 1999; 19: 32-36, 38.